New Treatment for Iron Overload: The Petadeferitrin Study

Are you or someone you know living with transfusion-dependent iron overload? Join our friendly webinar to learn about a promising new clinical study and an investigational drug called Petadeferitrin.

During this webinar session, you'll find out:

• What Petadeferitrin is and how it could help manage iron overload.

• What to expect from a clinical study and why they are essential for bringing new treatments to patients.

• How Petadeferitrin is being developed by Pharmacosmos.

We'll wrap up with a live Q&A where you can get answers directly from our presenters about the study and the future of iron overload care.

Why Your Involvement Matters

Clinical studies are the final, crucial step in developing new medicines. By taking part, you don't just potentially help yourself - you contribute to a better understanding of your condition. Your contribution could lead to new treatments that help your peers and future generations.

It is hoped that Petadeferitrin will be easier for patients to use and have fewer side effects than current treatments. Your participation is vital to exploring this possibility.

Anyone who takes part will receive compensation for their time and contribution.

Ready to learn more?

We're on the verge of some exciting advancements, and we'd love for you to join us to hear about what's next. If you want to learn more than join us online (via Microsoft Teams) on Thursday 25^th September 2025, 18:00 – 18:30

To register, click "select tickets." We'll send you the link to watch the webinar in a separate email as the event approaches.